Exhibit 99.1

 

 

Press Release

 

Eltek Ltd. Reports Third-Quarter 2026 Results

 

Petach Tikva, Israel (November 17, 2026) Eltek Ltd. (NASDAQ: ELTK), a leading global manufacturer of high-quality printed circuit boards, today announced its financial results for the quarter ended September 30, 2026.

 

Third Quarter 2026 Highlights

 

§Revenues were $12.0 million

 

§Operating loss was $1.6 million

 

§Net loss was $1.2 million, or $0.17 per fully diluted share

 

§Net cash provided by operating activities amounted to $0.04 million.

 

§$10.4 million in cash, cash equivalents and short-term bank deposits and no outstanding debt as of September 30, 2026.

 

Ron Freund, Chief Executive Officer, stated:

 

“Our third-quarter 2026 results reflect continued progress in our operational improvement initiatives, with a reduction in the Company's losses compared to the first two quarters of 2026.

 

During the quarter, we completed the installation of our 39-meter first plating line. Initial results from the trials conducted to date indicate significant improvements in both product quality and operational efficiency. We expect to complete the remaining optimization and validation processes over the coming months and anticipate beginning qualification processes with key customers in early 2027.

 

We continue to experience sustained demand for our products, supported by ongoing customer activity and new business opportunities. This positive momentum has contributed to an increase in our order backlog for the remainder of 2026 and into 2027.

 

In parallel, we have implemented tighter production planning and order management practices, with the objective of better aligning production capacity and schedules with customer-requested delivery dates, while maintaining operational discipline and improving execution.

 

We remain focused on executing our operational improvement plan, strengthening manufacturing stability, improving production efficiency, and enhancing customer satisfaction through transparency, open communication and a continued commitment to meeting our customers' expectations. These efforts are aimed at positioning Eltek to better capitalize on market demand and future growth opportunities."

 

 

Third Quarter 2026 GAAP Financial Results

 

Revenues for the third quarter of 2026 were $12.0 million compared to $13.3 million in the third quarter of 2025.

 

Gross profit for the third quarter of 2026 was $0.2 million (2% of revenues) compared to gross profit of $1.6 million (12% of revenues) in the third quarter of 2025.

 

Operating loss for the third quarter of 2026 was $1.6 million compared to operating profit of $0.05 million in the third quarter of 2025.

 

Financial income for the third quarter of 2026 was $0.3 million compared to financial expenses of $0.3 million in the third quarter of 2025. Financial income primarily resulted from the erosion of the NIS against the U.S. Dollar.

 

Net loss for the third quarter of 2026 was $1.2 million, or $0.17 per fully diluted share, compared to a net loss of $0.2 million, or $0.03 per fully diluted share, in the third quarter of 2025.

 

As of September 30, 2026, we had $10.4 million in cash, cash equivalents and short-term bank deposits and no outstanding debt.

 

Third Quarter 2026 Non-GAAP Financial Results

 

EBITDA loss for the third quarter of 2026 was $1.0 million compared to EBITDA of $0.6 million in the third quarter of 2025.

 

Nine Months Ended September 30, 2026 GAAP Financial Results

 

Revenues for the first nine months of 2026 were $34.0 million compared to $38.6 million in the first nine months of 2025.

 

Gross loss for the first nine months of 2026 was $2.6 million compared to gross profit of $6.8 million (18% of revenues) in the first nine months of 2025.

 

 

Operating loss for the first nine months of 2026 was $7.4 million compared to operating profit of $2.2 million in the first nine months of 2025.

 

Financial expenses for the first nine months of 2026 were $0.5 million compared to $0.8 million in the first nine months of 2025. Financial expenses primarily resulted from the erosion of the U.S. Dollar against the NIS.

 

Net loss for the first nine months of 2026 was $6.8 million, or $1.01 per fully diluted share, compared to net profit of $1.1 million, or $0.17 per fully diluted share, in the first nine months of 2025.

 

Nine Months Ended September 30, 2026 Non-GAAP Financial Results

 

EBITDA loss for the first nine months of 2026 was $5.6 million compared to EBITDA of $3.8 million in the first nine months of 2025.

 

About our Non-GAAP Financial Information

 

The Company reports financial results in accordance with U.S. GAAP and herein provides EBITDA, a non-GAAP measure. This non-GAAP measure is not in accordance with, nor is it a substitute for, GAAP measures. This non-GAAP measure is intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measure presented to evaluate and manage the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in a table below.

 

Conference Call

 

Today, Tuesday, November 17, 2026, at 8:30am Eastern Time (15:30pm Israel Time, 5:30am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by Ron Freund, Chief Executive Officer.

 

To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:

 

United States: 1-866-860-9642
Israel: 03-918-0691
International: +972-3-918-0691

 

 

To Access a Replay of the Call

 

A replay of the call will be available for 30 days on the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed.

 

About Eltek

 

Eltek – "Innovation Across the Board" – is a leading Israeli manufacturer of advanced printed circuit boards (PCBs), serving customers worldwide in demanding, technology-driven industries. Founded in 1970, the Company specializes in the design and manufacture of complex, high-reliability PCBs, including HDI, multilayer, rigid-flex and flexible boards, for mission-critical applications. Eltek serves leading customers in the defense, aerospace, medical and other advanced industries across Israel, North America, Europe and Asia. The Company combines advanced manufacturing capabilities, engineering expertise and internationally recognized quality standards, including AS9100D and NADCAP Electronics, to deliver high-performance solutions where quality and reliability are essential. Eltek is ITAR compliant.

 

Headquartered in Israel, Eltek operates advanced manufacturing and R&D facilities in Israel, a marketing subsidiary in North America and an international network of sales representatives and distributors. For more information, visit Eltek's web site at www.nisteceltek.com

 

Forward Looking Statement

 

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, changes in general economic, market and business conditions, the impact of currency movements between the US Dollar exchange rate against the Israeli Shekel, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, the sales cycle, risks associated with Eltek’s international operations and its location in Israel, including those arising from regional military conflicts and geopolitical instability, and other risk factors detailed in the Company’s Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.

 

Investor Contact

 

Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com

+972-3-939-5023

 

(Tables follow)

 

 

Eltek Ltd.
Consolidated Statements of Income
U.S dollars in thousands (except per share data)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
             
Revenues   12,019    13,267    33,989    38,552 
Costs of revenues   (11,789)   (11,671)   (36,575)   (31,725)
                     
Gross profit (loss)   230    1,596    (2,586)   6,827 
                     
Research and development expenses, net   -    -    -    (50)
Selling, general and administrative expenses   (1,854)   (1,546)   (4,851)   (4,546)
                     
Operating income (loss)   (1,624)   50    (7,437)   2,231 
                     
Financial income (expenses), net   295    (287)   (497)   (795)
                     
Income (loss) before income tax   (1,329)   (237)   (7,934)   1,436 
                     
Income tax expenses (tax benefit)   (172)   (6)   (1,180)   300 
                     
Net income (loss)   (1,157)   (231)   (6,754)   1,136 
                     
Earnings per share:                    
Basic net income (loss) per ordinary share   (0.17)   (0.03)   (1.01)   0.17 
                     
Diluted net income (loss) per ordinary share   (0.17)   (0.03)   (1.01)   0.17 
                     
Weighted average number of ordinary shares used to compute                    
basic net income (loss) per ordinary share (in thousands)   6,721    6,719    6,720    6,716 
                     
Weighted average number of ordinary shares used to compute                    
diluted net income (loss) per ordinary share (in thousands)   6,783    6,796    6,785    6,789 

 

 

Eltek Ltd.
Consolidated Balance Sheets
U.S dollars in thousands

 

   September 30,   December 31, 
   2026   2025 
     
Assets          
           
Current assets:          
Cash and cash equivalents   9,131    2,481 
Short-term bank deposits   1,248    9,643 
Trade receivables (net of allowance for credit losses)   10,761    14,789 
Inventories   10,197    11,154 
Other accounts receivable and prepaid expenses   595    607 
           
Total current assets   31,932    38,674 
           
Long term assets:          
Severance pay fund   74    65 
Deferred tax assets, net   1,664    387 
Operating lease right of use assets   12,102    6,272 
Total long term assets   13,840    6,724 
           
Property and equipment, net   24,099    20,862 
           
Total Assets   69,871    66,260 
           
Liabilities and Shareholder's equity          
           
Current liabilities:          
Trade payables   7,393    6,047 
Other accounts payable and accrued expenses   6,825    6,565 
Short-term operating lease liabilities   942    1,100 
           
Total current liabilities   15,160    13,712 
           
Long-term liabilities:          
Accrued severance pay   824    515 
Long-term operating lease liabilities   11,761    5,296 
           
Total long-term liabilities   12,585    5,811 
           
Shareholders' equity:          
Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at September 30, 2026 and December 31, 2025; Issued and outstanding: 6,722,393 shares at September 30, 2026 and 6,719,827 shares at December 31, 2025   6,014    6,012 
Foreign currency translation adjustments   7,877    6,111 
Additional paid-in capital   36,056    35,681 
Accumulated deficit   (7,821)   (1,067)
Total shareholders' equity   42,126    46,737 
Total liabilities and shareholders' equity   69,871    66,260 

 

 

Eltek Ltd.
Unaudited Non-GAAP EBITDA Reconciliations
U.S dollars in thousands

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
             
GAAP net income (loss)   (1,157)   (231)   (6,754)   1,136 
Add back items:                    
                     
Financial income (expenses), net   295    (287)   (497)   (795)
Income tax expenses (tax benefit)   (172)   (6)   (1,180)   300 
Depreciation   626    563    1,829    1,530 
Non-GAAP EBITDA   (998)   613    (5,608)   3,761 

 

 

Eltek Ltd.
Consolidated Statement of  Cash flow
U.S dollars in thousands

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
                 
Cash flows from operating activities:                    
                     
Net Income (loss)   (1,157)   (231)   (6,754)   1,136 
Adjustments to reconcile net income to net cash flows                    
provided by operating activities:                    
Depreciation   626    563    1,829    1,530 
Unrealized financing expenses (income), net   55    11    (100)   477 
Share-based compensation   119    131    361    401 
Decrease (increase) in deferred tax assets   (211)   27    (1,275)   229 
    589    732    815    2,637 
                     
Decrease (increase) in operating lease right-of-use assets   166    19    477    19 
Decrease (increase) in trade receivables   603    626    4,691    (1,107)
Decrease (increase) in other receivables and prepaid expenses   350    (10)   38    237 
Decrease (increase) in inventories   (179)   857    1,435    (1,755)
Increase (decrease) in trade payables   (871)   (137)   (642)   (2,137)
Increase (decrease) in other liabilities and accrued expenses   278    127    (12)   99 
Increase (decrease)  in employee severance benefits, net   265    19    285    65 
    612    1,501    6,272    (4,579)
                     
Net cash provided by (used in) operating activities   44    2,002    333    (806)
                     
Cash flows from investing activities:                    
Purchase of fixed assets   (750)   (1,386)   (2,423)   (4,266)
Withdrawal of (investment in) short-term bank deposits, net   838    -    8,458    534 
Net cash provided by (used in) investing activities   88    (1,386)   6,035    (3,732)
                     
Cash flows from financing activities:                    
Exercise of options   11    28    16    36 
Dividend distribution   -    -    -    (1,276)
Issuance of shares, net   -    -    -    - 
Net cash provided by (used in) financing activities   11    28    16    (1,240)
                     
Effect of translation adjustments   (402)   (290)   266    327 
                     
Net increase (decrease) in cash and cash equivalents   (259)   354    6,650    (5,451)
                     
Cash and cash equivalents at the beginning of the period   9,390    1,770    2,481    7,575 
                     
Cash and cash equivalents at the end of the period   9,131    2,124    9,131    2,124